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Abstract
Background: Hypoxia and hypoxia-reoxygenation (H-R) are pathogenic factors in many liver diseases that lead to
hepatocyte death as a result of reactive oxygen species (ROS) accumulation. The tumor necrosis factor super-family member
CD154 can also induce hepatocyte apoptosis via activation of its receptor CD40 and induction of autocrine/paracrine Fas
Ligand/CD178 but the relationship between CD40 activation, ROS generation and apoptosis is poorly understood. We
hypothesised that CD40 activation and ROS accumulation act synergistically to drive human hepatocyte apoptosis.
Methods: Human hepatocytes were isolated from liver tissue and exposed to an in vitro model of hypoxia and H-R in the
presence or absence of CD154 and/or various inhibitors. Hepatocyte ROS production, apoptosis and necrosis were
determined by labelling cells with 29,79-dichlorofluorescin, Annexin-V and 7-AAD respectively in a three-colour reporter flow
cytometry assay.
Results: Exposure of human hepatocytes to recombinant CD154 or platelet-derived soluble CD154 augments ROS
accumulation during H-R resulting in NADPH oxidase-dependent apoptosis and necrosis. The inhibition of c-Jun N-terminal
Kinase and p38 attenuated CD154-mediated apoptosis but not necrosis.
Conclusions: CD154-mediated apoptosis of hepatocytes involves ROS generation that is amplified during hypoxia-
reoxygenation. This finding provides a molecular mechanism to explain the role of platelets in hepatocyte death during
ischemia-reperfusion injury.
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Introduction
Hepatocyte death is central to most liver diseases and is
frequently associated with tissue hypoxia. Hypoxia can also occur
as a result of ischaemia associated with hepatic surgery or liver
transplantation where reoxygenation follows hypoxia and may
further exacerbate tissue injury and promote liver inflammation.
Central mediators of hepatocyte cell death during hypoxia are the
reactive oxygen species (ROS) [1]. ROS, which include superox-
ide anions, hydrogen peroxide, hypohalus acid and hydroxyl
radicals, accumulate in the many liver diseases and have also been
implicated in the preservation/reperfusion injury that follows liver
transplantation [2].
Under physiological conditions hepatocytes exist in a relatively
hypoxic micro-environment [3] which promotes the generation of
ROS. Consequently hepatocytes have several cellular mecha-
nisms, including high intracellular glutathione levels, which
counteract increases in ROS and thereby limit parenchymal
injury [4,5]. It has long been assumed that extracellular ROS,
released by Kupffer cells (KCs) and infiltrating neutrophils are the
main contributors to hepatocyte injury [6]. However, we recently
reported that intracellular ROS can also regulate human
hepatocyte cell death during hypoxia and hypoxia-reoxygenation
(H-R) [2]. In this micro-environment, hepatocytes will be exposed
to an array of pro-inflammatory mediators including cytokines
which may augment intracellular ROS production and amplify
liver injury.
CD40 and its ligand CD154, members of the tumor necrosis
factor-(TNF) receptor/ligand superfamily are known to regulate
hepatocyte apoptosis [7] and have been implicated in hepatocyte
death during hypoxia [8]. CD40 is a type I trans-membrane
protein receptor and expressed as a trimeric complex upon the cell
surface of many cells including hepatocytes, endothelial cells and
cholangiocytes. CD154, a type II trans-membrane protein, is
expressed by CD4
+ T-lymphocytes, macrophages, mast cells and
basophils. It is also expressed by platelets and released in a soluble
form following platelet activation. Studies in CD40 and CD154
deficient mice have implicated this pathway in hypoxic liver injury
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30867[8,9]. The mechanism was assumed to involve defective
CD40:CD154 priming of T-lymphocytes. However, we have
previously reported that activation of CD40 on hepatocytes or
cholangiocytes can induce Fas Ligand (FasL/CD178) expression
and autocrine/paracrine Fas-mediated apoptosis [7,10].
CD40:CD154 interactions have also been shown to mediate
ROS accumulation in the WEHI231 lymphoid cell line [11]
leading us to hypothesise that CD40 activation could be implicated
in ROS-mediated hepatocyte death.
Following ligation by trimeric CD154, CD40 is activated and
internalized. CD40 has no active intracellular kinase domain and
binds to members of the tumor necrosis factor receptor-associated
factor (TRAF) family which are responsible for activating
downstream signaling pathways. In lymphoid cells, TRAFs recruit
the cystolic enzyme nicotinamide adenine dinucleotide phosphate
oxidase (NADPH oxidase) to the plasma membrane providing a
potential mechanism to generate ROS [11]. We now report that in
primary human hepatocytes, CD40 ligation leads to NADPH-
dependent intracellular ROS generation and hepatocyte death in
hypoxic conditions demonstrating for the first time how TNF
receptor activation and ROS can co-operate to mediate epithelial
cell injury in chronic inflammation and hypoxia/reperfusion
injury.
Materials and Methods
Ethics Statement
Liver tissue was obtained from surgical procedures carried out
at the Queen Elizabeth Hospital, Birmingham, UK. Ethical
approval for the study was grant by the Local Research Ethics
Committee (LREC) (Leicestershire and Rutland Ethics Committee
- reference number 06/Q702/61). Informed written consent was
obtained from all participants involved in the study.
Human Hepatocyte Isolation
Liver tissue was obtained from fully consenting patients
undergoing transplantation, hepatic resection for liver metastasis,
hepatic resection for benign liver disease or normal donor tissue
surplus to surgical requirements. Human hepatocytes were isolated
using a method that we have described previously [2,12].
Model of hypoxia and H-R injury
We used a model of in vitro hypoxia and H-R that we have
described previously [2]. In experiments involving the NADPH
oxidase inhibitor, DPI; JNK inhibitor SP600125, or p38 inhibitor,
PD169316, all reagents were made fresh as stock solutions and
added using the correct dilutional factor to the relevant experi-
mental wells. Specifically, 10 mg DPI (Sigma) was dissolved in
molecular grade dimethyl sulfoxide (DMSO), 10 mg rotenone
(Sigma) was dissolved in chloroform (Sigma), 50 mg SP600125
(Sigma) was dissolved in DMSO and 50 mg PD169316 (Sigma) was
dissolved in DMSO and were diluted appropriately to give working
concentrations of 10 mM, 2 mM, 10 mMa n d1 0mM respectively. In
experiments using inhibitors/antioxidants, solvent alone wells were
used to control for vehicle effects. In experiments using inhibitors/
antioxidants hepatocytes were pre-treated with agents for up to
4 hours before placement of the cells into normoxia and hypoxia.
For H-R experiments fresh inhibitor/antioxidants were added at
the time of placement into reoxygenation. Recombinant human
soluble CD154 (1 mg/mL, Enzo Life Sciences, UK) and 1 mg/mL
Cross-linker for Ligands (Enzo Life Sciences, UK) were added to
cells at the time of entry into hypoxia or H-R. Where cells had been
pre-treated with inhibitors/antioxidants CD154 and Cross-linker
for Ligands were added after 4 hours.
Determination of Human Hepatocyte CD40 Expression
and FasL Expression
Following appropriate incubation of human hepatocytes within
normoxia, hypoxia and H-R, cells were trypinised and washed in
FACs buffer (Phosphate-buffered saline (PBS) pH 7.2 with 10% v/
v heat inactivated foetal calf serum (Gibco). For CD40 expression,
cells were then incubated with anti-human CD40 antibody that
was conjugated to the APC fluorophore (1:100 dilution; Caltag,
UK) for 45 min at 4uC. Mouse IgG1-APC (1:100 dilution; Caltag,
UK) was used as a negative control. For FasL expression, cells
were then incubated with anti-human FasL antibody that was
conjugated to the FITC fluorophore (1:100 dilution; Abcam, UK)
for 45 min at 4uC. Mouse IgG2a-FITC (1:100 dilution; Abcam,
UK) was used as a negative control. Following this cells were
washed in FACs buffer and resuspended in PBS, pH 7.2. At least
20,000 events were recorded within the gated region of the flow
cytometer for each human hepatocyte cell preparation in each
experimental condition. Only the cells within the gated region
were used to calculate Mean Fluorescence Intensity (MFI) as
described in our previous study [2].
Determination of Human Hepatocyte ROS Accumulation,
Apoptosis and Necrosis
ROS production, apoptosis and necrosis were determined using
a three-colour reporter assay system as previously described [2]. At
least 20,000 events were recorded within the gated region of the
flow cytometer for each human hepatocyte cell preparation in
each experimental condition. Only the cells within the gated
region were used to calculate MFI.
Platelet isolation and activation
Platelets were isolated by modifying a previously published
method from fully consenting healthy individuals [13]. Platelet-rich
plasma (PRP) was prepared by centrifuging 5 mL of heparinised
blood for 5 min at 3006g. Following this the PRP was withdrawn
andtheplatelet count adjusted to 1610
6 platelets/mL inWilliamsE
media. Platelets were then seeded onto plastic. Following 30 min
incubation at room temperature the platelets had settled, become
activated and spread to form a confluent monolayer. The Williams
media was then aspirated and passed through a 0.2 mm syringe
filter. The PCM was aliquoted and frozen at 270uC until required.
Media was thawed and added to cells as required.
Determination of Soluble CD154 and Immunomagnetic
Depletion of CD154 from PCM
To confirm the presence and quantity of CD154 in the PCM
levels were quantified by ELISA and platelet-derived CD154 was
removed via immuno-magnetic depletion. Briefly, soluble human
CD154 was measured in both PCM and CD154-depleted PCM
using a sandwich ELISA kit (Peprotech, UK). For immunomag-
netic depletion of CD154, anti-human CD154 antibody (1 mg/
mL; Abcam, UK) was complexed to pan-mouse IgG magnetic
Dynabeads (Invitrogen, Paisley, UK) for 90 min at room
temperature. Following this, the antibody-magnetic bead com-
plexes were extensively washed. Complexes were then incubated
with PCM for a further 90 min at room temperature. Finally,
magnetic beads were retrieved from solutions and this media was
subsequently used in experiments as CD154-depleted PCM.
Statistical Analysis
All data are expressed as mean 6 S.E. Statistical comparisons
between groups were analysed by Student’s t test. All differences
were considered statistically significant at a value of p,0.05.
CD40 Dependent Human Hepatocyte Cell Death
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CD40 expression in human hepatocytes during hypoxia
and H-R
Primary human hepatocytes constitutively expressed CD40 on
the cell membrane as previously reported [14] but this did not
increase in response to hypoxia or H-R in vitro (Figure 1).
CD40:CD154 stimulates ROS accumulation in human
hepatocytes in an NADPH-dependent manner and
regulates apoptosis and necrosis
We have recently reported that intracellular ROS accumulate in
hypoxic human hepatocytes and that this is increased further during
H-R [2]. Here we investigated whether CD154 could augment
human hepatocyte ROS production during normoxia, hypoxia and
H-R. Trimeric recombinant human CD154 significantly increased
intracellular ROS accumulation within human hepatocytes during
normoxia and H-R but not hypoxia. Because CD40:CD154 has been
shown to mediate ROS accumulation via TRAF-dependent recruit-
ment of the flavoenzyme NADPH oxidase in lymphoid cell lines [11]
we used the specific NADPH oxidase inhibitor Diphenyliodonium
(DPI) to assess the involvement of this pathway in ROS generation by
human hepatocytes. DPI reduced hepatocyte CD154 mediated ROS
production during normoxia, hypoxia and H-R (Figure 2a & 2b).
The increased levels of intracellular ROS induced by CD154
stimulation, during normoxia and H-R, increased human
hepatocyte apoptosis and to a lesser extent necrosis (Figure 2c &
2d) and this were reduced by pre-treatment with DPI. CD154 also
significantly increased human hepatocyte necrosis during nor-
moxia and H-R that was inhibited by DPI demonstrating that that
the CD40:CD154:ROS signaling pathway is NADPH-dependent
and results in hepatocyte death.
Mitochondrial ROS has been implicated in hepatocyte apoptosis
duringhypoxia and H-R [2] leading us to test the effect of inhibiting
mitochondrial ROS production upon CD154 mediated apoptosis
with the complex I inhibitor, rotenone. Inhibiting mitochondrial
ROS production during normoxia and H-R did not reduce human
hepatocyte apoptosis in response to CD154 treatment but did
reduce apoptosis during hypoxia (Figure 2e).
JNK and p38 regulate apoptotic but not necrotic cell
death in human hepatocytes
We next investigated whether CD40:CD154 generated ROS
and hepatocyte death was associated with activation of mitogen-
Figure 1. CD40 Expression on Primary Human Hepatocytes. Figure 1a demonstrates a representative flow cytometry plot of CD40 expression
on primary human hepatocytes during normoxia, hypoxia and H-R. The plot on the left hand side represents a typical forward scatter (FS) versus side
scatter (SS) plot of primary human hepatocytes. The FS versus SS plots shown is from the H-R sample of a liver preparation but similar plots were
obtained during normoxia and hypoxia (data not shown). Figure 1b shows a bar chart with the pooled data of three separate experiments illustrating
the level of CD40 expression on primary human hepatocytes. Data are expressed as MFI and readings are based upon values taken from cells within
the gated region in Figure 1a.
doi:10.1371/journal.pone.0030867.g001
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sequentially activated kinase modules, namely mitogen-activated
protein kinase kinase kinases (MAPKKK/MAP3K) followed by
the mitogen-activated protein kinase kinases (MAPKK/MEKK)
and finally the MAPKs. The MAPKs superfamily consists of three
separate sub-families; extra-cellular regulated protein kinase
(ERK), c-Jun N-terminal kinase (JNK) and p38. ERK is generally
involved in the regulation of cell proliferation and differentiation,
whereas JNK and p38 are involved in the regulation of cell death
[15].
Unfortunately, primary human hepatocytes are not amenable to
siRNA transfection or protein labeling [16,17,18]. Therefore to
investigate the effects of JNK and p38 inhibition upon
CD154:ROS mediated human hepatocyte apoptosis we used
specific JNK and p38 inhibitors [19,20,21]. Inhibition of JNK and
p38 in hepatocytes using the specific inhibitors SP600125 and
Figure 2. CD40:CD154 regulates ROS accumulation, apoptosis and necrosis within human hepatocytes in a NADPH Oxidase
dependent manner during normoxia and H-R. Figure 2a demonstrates representative flow cytometry plots to illustrate the effect of CD154
(hatched red) and CD154 in presence of DPI (solid grey) upon human hepatocyte ROS accumulation during normoxia, hypoxia and H-R. Typical FS
versus SS plots of primary human hepatocytes during normoxia, hypoxia and H-R are shown to the left of each flow cytometric plot. The FS versus SS
plots shown is from the H-R alone sample of a liver preparation but similar plots were obtained during normoxia and hypoxia (data not shown). The
areas of interest on the flow cytometric plots are marked by the vertical ellipses. The area on the left of each ellipse represents cell debris. Cell debris
is included within the plot as human hepatocytes vary considerably in size and therefore to include all viable human hepatocytes in the analysis a
large gate is required on the flow cytometer, this by necessity includes the cell debris. Figure 2b. shows a bar chart with the pooled data of three
separate experiments illustrating the effects of CD154 and CD154+DPI upon human hepatocytes ROS accumulation. Data is expressed as MFI and
readings are based upon values taken from cells within the gated region shown in Figure 2a. Data are expressed as mean 6 S.E. (*p,0.01 relative to
basal, **p,0.05 relative to basal, {p,0.001 relative to CD154). Figure 2c demonstrates representative flow cytometry plots to illustrate the effect of
CD154 (hatched red) and CD154 in presence of DPI (solid grey) upon human hepatocyte apoptosis and necrosis during normoxia, hypoxia and H-R.
Again, the area of interest within the flow cytometric plots is marked by the vertical ellipse. The same gate has been applied to primary human
hepatocytes for these plots as those shown in Figure 2a. Figure 2d. shows a bar chart with the pooled data of three separate experiments illustrating
the effects of CD154 and CD154+DPI upon human hepatocytes apoptosis and necrosis during normoxia, hypoxia and H-R. Data is expressed as
increase/decrease relative to basal, where basal refers to the level of apoptosis or necrosis during normoxia alone. Data are expressed as mean 6 S.E.
(**p,0.01 relative to basal, *p,0.05 relative to basal, {p,0.05 relative to CD154, 1p,0.05 relative to basal). Figure 2e. Human hepatocytes were
treated with CD154 or CD154 following pre-treatment with rotenone (Rot) during normoxia, hypoxia and H-R. The percentage of cells staining with
both the ROS probe DCF and apoptotic marker, Annexin-V, were assessed by flow cytometry. The percentage of human hepatocytes that stain for
both DCF and Annexin-V are shown in parentheses. Data are representative of 3 separate experiments ({p,0.05 relative to basal, *p,0.05 relative to
CD154).
doi:10.1371/journal.pone.0030867.g002
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hypoxia and H-R (data not shown) whereas they significantly
decreased CD40:CD154 mediated human hepatocyte apoptosis
during normoxia, hypoxia and H-R (Figure 3a, 3b & 3c).
Inhibition of p38 had a greater effect on hepatocyte apoptosis
than JNK inhibition. Neither inhibitor reduced CD154 mediated
hepatocyte necrosis under any of the experimental conditions
(Figure 3). This suggests that CD40:CD154 mediated human
hepatocyte apoptosis during normoxia and H-R is ROS, JNK and
p38-dependent whilst necrosis is ROS-dependent but MAPK-
independent.
CD40:CD154:NADPH oxidase interactions stimulate
hepatocyte Fas ligand expression
Fas is a cell surface receptor of the TNF Receptor superfamily
which, when activated by FasL, induces apoptosis on a wide range
of cells including hepatocytes [7]. Because we have previously
reported the CD40 activation on human hepatocytes results in
Fas-mediated apoptosis, we investigated whether hypoxia or H-R
alone or in association with CD154 induced FasL expression.
Neither hypoxia nor H-R increased hepatocyte cell surface FasL
expression (Figure 4a). However, CD40:CD154 increased FasL
expression during hypoxia and H-R, with a greater effect during
hypoxia. Inhibiting NADPH oxidase function with DPI reduced
CD40:CD154 mediated FasL expression during hypoxia and H-
R, with a greater effect noted during H-R (Figure 4b & 4c).
Platelet-derived soluble CD154 mediates hepatocyte
apoptosis and necrosis
Finally, because platelets are the source for 95% of circulating
soluble CD154 and activated platelets may be found in the liver
parenchyma during damage [22] we determined whether
activated platelets may be a potential source of functionally active
CD154 during hypoxia and H-R.
Figure 3. JNK and p38 regulate CD40:CD154 mediated human hepatocyte apoptosis but not necrosis. Figure 3a show representative
flow cytometry plots to illustrate the effect of the JNK inhibitor SP600125 upon CD40:CD154 mediated apoptosis and necrosis during normoxia,
hypoxia and H-R. The gate used to analyse primary human hepatocytes is the same as that shown in Figures 1 & 2. The area of interest within the flow
cytometric plots are marked by the vertical ellipses. Figure 3b illustrates the effects of the p38 inhibitor P169316 upon CD40:CD154 mediated
apoptosis and necrosis during normoxia, hypoxia and H-R. Figure 3c shows a bar chart with the pooled data of three separate experiments illustrating
the effects of both SP600125 and PD169316 upon CD40:CD154 mediated human hepatocyte apoptosis and necrosis during normoxia, hypoxia and
H-R. Data are expressed as increase/decrease relative to basal, where basal refers to the level of apoptosis or necrosis during normoxia alone. Data are
expressed as mean 6 S.E. (**p,0.01 relative to basal, *p,0.05 relative to basal, {p,0.05 relative to CD154, {{p,0.05 relative to basal).
doi:10.1371/journal.pone.0030867.g003
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by activated platelets by .70% (Platelet Conditioned Media
(PCM) soluble CD154 concentration 22516310 pg/mL; CD154-
depleted PCM CD154 concentration 590679 pg/mL). PCM
increased hepatocyte intracellular ROS accumulation during H-R
(Figure 5a). When CD154 was depleted from PCM, intracellular
ROS accumulation was significantly reduced during H-R. PCM
increased human hepatocyte apoptosis during H-R mirroring the
increasing in intracellular ROS (Figure 5b). However, in line with
the decrease in ROS seen during H-R, CD154-depleted PCM
decreased human hepatocyte apoptosis during H-R (Figure 5b).
Discussion
Tissue hypoxia is a feature of hepatic inflammation and disease
[23] and we have recently shown the accumulation of intracellular
ROS is a critical mediator of hepatocyte death during hypoxia and
H-R [2]. In the present report we show that ROS accumulation in
human hepatocytes during hypoxia and H-R is increased by
CD154 mediated activation of hepatocyte CD40 resulting in
increased cell death. This link between CD40 activation,
intracellular ROS generation and cell death has implications for
other inflammatory diseases characterised by local hypoxia.
CD40:CD154 receptor-ligand interactions have been associated
with parenchymal injury during hypoxia and H-R in many organs
[8,24,25] and disruption of CD40:CD154 signaling in mice
improves liver function following hypoxia [8]. However until now
it was thought that CD40:CD154 mediates its actions through
effects on T-lymphocyte priming whereas our data suggest another
mode of action through direct effects on hepatocyte survival. We
have previously reported that CD40 activation mediates Fas
dependent apoptosis in human hepatocytes through induction of
autocrine FasL expression [7]. We now demonstrate that
CD40:CD154 can also mediate human hepatocyte apoptosis
and necrosis in a NADPH Oxidase:ROS-dependent manner. This
introduces a previously unknown CD40 dependent pathway to cell
Figure 4. FasL Expression on Primary Human Hepatocytes. Figure 4a demonstrates a representative flow cytometry plot of FasL expression
on primary human hepatocytes during normoxia, hypoxia and H-R. The gate used to analyse primary human hepatocytes is the same as that shown
in Figures 1 & 2. Figure 4b. demonstrates representative flow cytometry plots to illustrate the effect of CD154 (hatched red) and CD154 in presence of
DPI (solid grey) upon human hepatocyte FasL expression during normoxia, hypoxia and H-R. Figure 4c. shows a bar chart with the pooled data of
three separate experiments illustrating the effects of CD154 upon human hepatocyte FasL expression during normoxia, hypoxia and H-R. Data are
expressed as MFI and readings are based upon values taken from cells within the gated region in Figure 1a. Data are expressed as mean 6 S.E.
(*p,0.05 relative to basal, **p,0.05 relative to CD154).
doi:10.1371/journal.pone.0030867.g004
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tissue hypoxia and H-R.
Our data also support an important role for intrinsic ROS
accumulation in hepatocytes as opposed to the current model
which suggests that ROS is derived from leukocytes [6]. CD40
activation did not increase ROS accumulation or cell death in
human hepatocytes during hypoxia and this is probably a
consequence of the increased antioxidant levels induced in
hepatocytes during hypoxia [26]. This may also explain why
FasL has little effect during hypoxia (see below). Furthermore,
hypoxia alone did not increase hepatocyte cell surface CD40
implying that the lack of effect of CD154 during hypoxia was
probably a consequence of the modulation of intracellular
signaling pathways by antioxidants rather than changes in CD40
receptor bioavailability.
Our data clearly show that increases in intracellular ROS
induced by CD154 are dependent upon NADPH Oxidase, this is
consistent with previous studies implicating NADPH in ROS
accumulation in hypoxic human hepatocytes during normoxia,
hypoxia and H-R [2]. Studies in WEHI 231 cells and endothelial
cells have shown that following activation, CD40 recruits NADPH
Oxidase to the plasma membrane via a mechanism involving
TRAF3 [11,27,28,29]. Once at the plasma membrane the p40
phox
subunit of NADPH oxidase can generate ROS leading to
activation of a number of downstream cell death signaling
pathways (Figure 6). In our primary human hepatocyte model,
CD40:NADPH oxidase:ROS initiated apoptosis and to a lesser
extent necrotic cell death. The mode of hepatocyte cell death
stimulated by hypoxia remains controversial. Both apoptosis and
necrosis have been implicated in transplant models [30] consistent
Figure 5. The effects of PCM and PCM CD154-depleted upon human hepatocyte ROS accumulation and cell death. Figures 5a
demonstrates representative flow cytometry plots to illustrate the effect of PCM (hatched red) and PCM CD154-depleted (solid grey) upon human
hepatocyte ROS accumulation during H-R. The gate used to analyse primary human hepatocytes is the same as that shown in Figures 1 & 2. The area
of interest within the flow cytometry plots is marked by the vertical ellipse. The area on the left of each ellipse again represents cell debris. Figure 5b,
human hepatocytes were treated with PCM or PCM CD154-depleted during H-R and the percentage of cells staining with both the ROS probe DCF
and apoptotic marker, Annexin-V, were assessed by flow cytometry.. The percentage of human hepatocytes that stain for both DCF and Annexin-V
are shown in parentheses. Data is representative 3 separate experiments (*p,0.05 relative to basal, **p,0.05 relative to PCM).
doi:10.1371/journal.pone.0030867.g005
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common mediator regulates both forms of cell death during
hypoxia and H-R [31]. We propose that CD40:CD154 activation
in hepatocytes has at least three downstream consequences 1)
initiation of apoptosis mediated via ROS 2) initiation of apoptosis
mediated via FasL induction and 3) necrosis.
CD40 activation results in apoptotic death in many cells of
epithelial lineage [7,14]. Indeed, CD40 activation induces human
hepatocyte apoptosis via up-regulation of FasL expression and
subsequent Fas-mediated apoptosis [7]. Moreover, in human
hepatocytes, it is the sustained activation of Activator Protein-1
(AP-1) and MAPKs, and not NF-kappaB, which is central to
initiating apoptosis [32]. A similar signalling pathway has been
reported in mediating cholangiocytes apoptosis after CD40
ligation [33]. Additionally, in cholangiocytes, CD40 mediated
apoptosis also requires the activation of the JAK2-STAT3
pathway and the downstream activation of caspase-3 [14].
However, our study is the first to implicate ROS in this process
of epithelial and specifically human hepatocyte, apoptosis. ROS
can activate the MAPKs sub-families of JNK and p38, important
regulators of cell death. Specifically, ROS can activate the
MAP3K, apoptosis signaling kinase 1 (ASK1) resulting in
phosphorylation of MEK 3/6 [34] and MEK 4/7 [34] which
respectively activate p38 and JNK. Inhibition of p38 [35] and JNK
[36] improves hepatocyte viability after hypoxia and during H-R
in rodent models. We now show that CD40:CD154 mediated
human hepatocyte apoptosis is reduced by JNK inhibition and
prevented by p38 inhibition. The precise mechanism of JNK
mediated apoptosis is controversial. JNK can act upstream of
mitochondria by activating the pro-apoptotic Bcl2 family [37] and
also increases turnover of the anti-apoptotic protein c-FLIP [38].
p38 is thought to mediate apoptosis via phosphorylation of Bcl2
family members [39] and CD40-mediated-NADPH oxidase
generated ROS is upstream of p38 activation in WEHI 231 cells
[11]. Thus our data report for the first time a mechanistic link
between CD40:CD154 mediated ROS generation, MAPK
activation and cell death. Taken together, these studies highlight
the complexities of the upstream CD40 signaling pathway and
suggest that CD40 can couple to at least ROS and AP-1 signaling
pathways to regulate apoptosis. Whether CD40 ligation in human
hepatocytes can also active the JAK-STAT pathways, as seen in
cholangiocytes, remains to be ascertained.
Figure 6. Proposed mechanism of CD40-CD154 mediated apoptosis and necrosis in human hepatocytes during normoxia, hypoxia
and H-R. During normoxia (blue arrows) activation of CD40 expressed upon human hepatocyte by CD154 results in the translocation of the TRAF
adaptor molecules to the cell membrane. The TRAF molecules are then responsible for the recruitment of the flavoenzyme NADPH Oxidase to the
CD40:TRAF complex. Here NADPH Oxidase can induce the production of ROS, primarily in the form of hydrogen peroxide. This process can be
inhibited by the NADPH Oxidase inhibitor DPI. The resultant accumulation of ROS can result directly in necrotic cell death or it can activate the MAPK
members, JNK and p38, to induce human hepatocyte apoptosis. However, during hypoxia (red arrows) CD40 activation on human hepatocytes does
not result in ROS accumulation but can induce FasL expression via mechanisms that NADPH Oxidase-dependent and ROS-independent (dotted black
line). This increased FasL expression can result in autocrine (green arrow) and/or paracrine (orange arrows) Fas-mediated apoptosis. Due to the
increases in intracellular antioxidants levels during hypoxia CD154 does not increase apoptosis. However, mitochondrial ROS does contribute to
apoptosis during hypoxia. During H-R, CD40 activation can lead to NADPH Oxidase-ROS-JNK/p38 dependent apoptosis, NADPH Oxidase-ROS-
dependent necrosis and NADPH Oxidase:ROS:FasL expression with resultant Fas-mediated apoptosis. Figure 6 highlights the importance of local
microenvironment in shaping the effects of CD40:CD154.
doi:10.1371/journal.pone.0030867.g006
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resulting in autocrine/paracrine Fas-mediated apoptosis in human
hepatocytes [7]. However, in contrast to in vivo studies [40],
hypoxia and H-R did not result in increased hepatocyte FasL
expression in our study. We confirmed that CD154 induced cell
surface expression of FasL in human hepatocytes and showed for
the first time that this is in part dependent on NADPH oxidase
particularly during H-R. This suggests that other mechanisms are
involved in regulating ROS-independent FasL expression. As
discussed above, although CD40:CD154 did not increase ROS
during hypoxia, it did increase FasL expression although without a
concomitant increase in apoptosis. However, the inhibition of
mitochondrial ROS significantly reduced hepatocyte apoptosis
during hypoxia. Fas mediated apoptosis in hepatocytes requires
the downstream accumulation of mitochondrial ROS [41] and
together with likely increases in hepatocytes antioxidant levels
during hypoxia explains why we saw increased FasL expression in
the absence of apoptosis in response to CD40 activation [4,5].
This also suggests that different apoptotic signaling pathways may
be initiated in response to CD40 activation under different
conditions in distinct microenvironments.
Our data suggest that hypoxia, which precedes reoxygenation
during preservation of an organ allograft for transplantation, can
increase FasL expression thereby initiating liver damage before
ROS generation during reperfusion has occurred. FasL is also
increased on hepatocytes in chronically inflamed livers a situation
characterized by tissue hypoxia. Thus the mechanism we describe
is likely to operate in the chronic inflammation where large
numbers of CD154 expressing effector cells can activate CD40 in
a hypoxic environment [42].
We have previously reported that ROS generation can regulate
human hepatocyte necrosis during hypoxia and H-R [2] and
hepatocyte necrosis has been induced experimentally during
hypoxia followed by reoxygenation [31]. We show that ROS
generated by CD40:CD154 not only induces hepatocyte apoptosis
but also necrosis during normoxia and H-R. This process is
NADPH Oxidase dependent as shown by the decrease in necrosis
in the presence of DPI but in contrast to CD154-mediated
hepatocyte apoptosis, necrosis is MAPK-independent. This
suggests that NADPH oxidase generated ROS regulates divergent
signaling pathways leading to both forms of cell death.
Therefore, coupled with previous work regarding CD40
mediated death of liver epithelial cells it is clear that the signaling
pathways regulating this process are diverse. Clearly, in the
present manuscript we demonstrate that CD154:CD40:ROS is an
important activator of JNK and p38 which subsequently leads to
cell death. However the JAK2-STAT3 is also important CD40
mediated apoptotic pathway [14] that may also be activated by
ROS. Furthermore FasL is also up-regulated following CD40
activation. Therefore CD40 regulates multiple death signaling
pathways in liver epithelial cells.
We have shown that macrophages and T-lymphocytes are an
abundant source of CD154 in the chronically inflamed liver [43].
However platelets are also a rich source of CD154 [22] and within
seconds of activation CD154 is translocated to the platelet surface
then cleaved to produce soluble CD154. Platelets have been
implicated in preservation injury during liver transplantation and
in other conditions including immune mediated damage in
hepatitis although the mechanisms of the effect are poorly
understood [44,45,46]. We now show that activated platelets
secrete functional CD154 that is capable of inducing ROS
accumulation in human hepatocytes during H-R leading to
hepatocyte apoptosis. This finding provides a novel mechanism
to explain the effector function of platelets in liver injury and
suggests that anti-platelet therapy together with anti-oxidants may
be warranted not only to prevent reperfusion injury but also to
reduce liver injury in chronic hepatitis and cirrhosis in which
platelets are found in close proximity to hepatocytes [47,48].
Although our findings suggest that platelets are a major source of
CD154 capable of inducing injury as previously suggested [25]
CD154 depletion from platelet-conditioned medium reduced but
did not abolish human hepatocyte apoptosis suggesting either that
there was residual CD154 activity in the PCM or that platelets
release other active mediators of apoptosis [44].
In conclusion, we have shown that CD40:CD154 mediated
generation of ROS contributes to hepatocyte cell death by both
apoptosis and necrosis in the hypoxic liver microenvironment. The
ability of platelets as well as infiltrating T-lymphocytes and
macrophages to deliver functional CD154 to hepatocytes suggests
several potential mechanisms through which hepatocyte CD40
can be activated in the inflamed and hypoxic liver. The work
supports therapeutic intervention with anti-platelet and anti-
oxidant therapy in liver disease.
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